Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Dizal Pharmaceuticals, Huidagene Therapeutics, Nanjing Leads Biolabs.

Biopharmas in Asia-Pacific raising money in public or private financings: Antiverse, Nxera.

Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Acadia, Aditurn, Artic Vision, Avet, Clearside, Emcure, Leads, Neuren, Nobelpharma, Santen, Y-Mabs.

The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Dizal, Janssen, Moderna, Neurotech.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Akari, Peak.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allogene, Amgen, Astrazeneca, Aulos, Aummune, Indaptus, Kineta, Nektar, Nimbus, Paratek, Radella.

New hires and promotions in the biopharma industry, including: Altimmune, Climb, Longeveron, Rubedo.

Biopharmas raising money in public or private financings, including: Apimeds, Disc Medicine, Epibone, Travere.

The top 10 biopharma stock gainers and losers for the week.